I began writing these articles for The Monitor in an attempt to share with other principal investigators (PIs) the challenges and rewards of conducting pharmaceutical research in patients under my geriatric practice “wing.”
Knowing that current state-of-the-art pharmaceuticals are always needing safer and more effective profiles, I long ago began to involve myself in combining my geriatric medical practice with a small amount of Phase III and IV pharmaceutical testing. However, not having a mentor or role model while in medical school, nor a residency or fellowship, nor seeing any books on being a qualified PI, I set out to teach myself and eventually earned the Certified Physician Investigator (CPI®) designation. Over the past 25 years, I have learned great lessons in being a “true” PI, as opposed to the other type you may have heard about, for whom the initials mean “practically invisible.”
I also believe that GCP must stand for Great Clinical Practice, not Good Clinical Practice. I hope these many lessons learned over the past two-and-a-half decades can help mold future and current PIs into the highest quality of investigators possible. Let us put an end to the Practically Invisible PI!
Joel S. Ross, MD, FACP, AGSF, CMD, CPI, LLC
About the Author
Joel S. Ross, MD, FACP, AGSF, CMD, CPI, LLC, is founder, chairman, and president of the Memory Enhancement Centers of America, Inc., in Eatontown, N.J., a Phase I, II, and III Alzheimer’s disease evaluation and treatment center. He is also a clinical associate professor of medicine at Mount Sinai Medical Center in New York City. Dr. Ross also serves on the Board of Trustees for the Academy of Physicians in Clinical Research, an affiliate of ACRP.
99 Canal Center Plaza | Suite 200 | Alexandria, VA 22314
T: +1.703.254.8100 | F: +1.703.254.8101 | E: email@example.com
© 2015 Academy of Physicians in Clinical Research
Be a Part of APCR's Global Community!